Influence of Meal Schedule: Gender Differences

Sponsor
Hospital Universitari Vall d'Hebron Research Institute (Other)
Overall Status
Completed
CT.gov ID
NCT03773432
Collaborator
(none)
20
1
2
3.7
5.4

Study Details

Study Description

Brief Summary

Gender differences in the effect of meal schedule will be studied in a parallel design (10 women and 10 men). In two separate days a probe meal (290 stewed beans, 35 g bread, 100 mL water; 549 Kcal) will be administered in the afternoon, i.e. conventional schedule, and in the morning, i.e. unconventional schedule. The effect of meal schedule will be measured as the differences between the responses on both study days. Participants will be instructed to eat standard dinner the day before and to consume standard breakfast at home the day of the afternoon test. Studies will be conducted in a quiet, isolated room with participants siting on a chair. Perception will be measured at 5 min intervals 10 min before and 20 min after ingestion and at 10 min intervals up to 60 min after the probe meal.

Condition or Disease Intervention/Treatment Phase
  • Other: Probe meal
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Factors That Determine the Responses to Meal Ingestion: Meal Schedule and Gender Differences
Actual Study Start Date :
Aug 13, 2018
Actual Primary Completion Date :
Nov 16, 2018
Actual Study Completion Date :
Dec 4, 2018

Arms and Interventions

Arm Intervention/Treatment
Other: Men

In two separate days a probe meal (290 stewed beans, 35 g bread, 100 mL water; 549 Kcal) will be served at conventional and unconventional time.

Other: Probe meal
The probe meal will be administered either in the afternoon (conventional schedule) or in the morning (unconventional schedule).

Other: Women

In two separate days a probe meal (290 stewed beans, 35 g bread, 100 mL water; 549 Kcal) will be served at conventional and unconventional time.

Other: Probe meal
The probe meal will be administered either in the afternoon (conventional schedule) or in the morning (unconventional schedule).

Outcome Measures

Primary Outcome Measures

  1. Change in digestive well-being induced by meal schedule [1 day]

    Change in digestive well-being measured by a 10 cm scale graded from -5 (extremely unpleasant sensation) to +5 (extremely pleasant sensation) in response to afternoon and morning meals by repeated measures ANCOVA.

Secondary Outcome Measures

  1. Change in fullness sensation induced by meal schedule [1 day]

    Change in digestive well-being measured by a 10 cm scale graded from 0 (not at all) to 10 (very much) in response to afternoon and morning meals by repeated measures ANCOVA.

  2. Change in mood induced by meal schedule [1 day]

    Change in mood measured by a 10 cm scale graded from -5 (negative) to +5 (positive) in response to afternoon and morning meals by repeated measures ANCOVA.

  3. Change in hunger/satiety induced by meal schedule [1 day]

    Change in mood measured by a 10 cm scale graded from -5 (extremely hungry) to +5 (completely satiate) in response to afternoon and morning meals by repeated measures ANCOVA.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • non-obese
Exclusion Criteria:
  • history of gastrointestinal symptoms

  • prior obesity

  • use of medications

  • history of anosmia and ageusia

  • current dieting

  • alcohol abuse

  • psychological disorders

  • eating disorders

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Hospital Vall d'Hebron Barcelona Spain 08035

Sponsors and Collaborators

  • Hospital Universitari Vall d'Hebron Research Institute

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Hospital Universitari Vall d'Hebron Research Institute
ClinicalTrials.gov Identifier:
NCT03773432
Other Study ID Numbers:
  • PR(AG)338/2016G
First Posted:
Dec 12, 2018
Last Update Posted:
Dec 12, 2018
Last Verified:
Dec 1, 2018
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Hospital Universitari Vall d'Hebron Research Institute

Study Results

No Results Posted as of Dec 12, 2018